Literature DB >> 26001508

Reduction of radiation exposure during atrial fibrillation ablation using a novel fluoroscopy image integrated 3-dimensional electroanatomic mapping system: A prospective, randomized, single-blind, and controlled study.

Yan Huo1, Marian Christoph2, Mathias Forkmann2, Matthias Pohl2, Julia Mayer2, Jozef Salmas2, Judith Sitzy2, Carsten Wunderlich2, Christopher Piorkowski3, Thomas Gaspar3.   

Abstract

OBJECTIVE: We explored whether the use of a novel fluoroscopy image integrated 3-dimensional electroanatomic mapping (F-EAM) system could result in a reduction of overall fluoroscopy time and radiation doses during the whole procedure of atrial fibrillation (AF) ablation.
METHODS: Eighty patients (44 men (55%); mean age 63 ± 10 years) who underwent catheter ablation due to paroxysmal AF were recruited consecutively in the present study. Patients were randomized (1:1) into 2 arms for AF ablation: one using a conventional 3-dimensional electroanatomical mapping (EAM) system and the other using the F-EAM system.
RESULTS: Fluoroscopy time (10:42 [interquartile range {IQR} 8:45-12:46] minutes:seconds vs 1:45 [IQR 1:05-2:22] minutes:seconds; P < .001) and radiation doses (2440 [IQR 1593-3091] cGy·cm(2) vs 652 [IQR 326-1489] cGy·cm(2); P < .001) in the EAM group were significantly greater than those in the F-EAM group. The majority of reduction of radiation exposure was achieved after transseptal puncture, which was near-zero fluoroscopic exposure. In total, approximately 84% of fluoroscopy time and 73% of radiation doses have been reduced during the AF ablation procedure using the F-EAM system compared to using the conventional EAM system. However, procedure time did not differ significantly (1:39 [IQR 1:18-2:10] hours:minutes vs 1:37 [IQR 1:17-1:50] hours:minutes; P = .362). During follow-up (5.9 ± 1.3 months), 61 patients (76.3%) had no recurrence of atrial arrhythmias. The recurrence rate between the 2 groups did not differ.
CONCLUSION: AF catheter ablation using the F-EAM system was safe and resulted in a significant reduction of radiation exposure to patients and staff without complicating the workflow of the procedure. A near-zero fluoroscopic catheter ablation procedure could be performed without compromising acute/mid-term efficacy and safety.
Copyright © 2015 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Atrial fibrillation ablation; Fluoroscopy time; Paroxysmal atrial fibrillation; Radiation exposure; radiation doses; voltage map guided atrial fibrillation ablation

Mesh:

Year:  2015        PMID: 26001508     DOI: 10.1016/j.hrthm.2015.05.018

Source DB:  PubMed          Journal:  Heart Rhythm        ISSN: 1547-5271            Impact factor:   6.343


  14 in total

Review 1.  Mapping of atrial fibrillation: strategies to understand an enigmatic arrhythmia.

Authors:  Isabel Deisenhofer
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2018-09-13

2.  Implementation of a near-zero fluoroscopy approach in interventional electrophysiology: impact of operator experience.

Authors:  Severin Wannagat; Lena Loehr; Sebastian Lask; Katharina Völk; Tamer Karaköse; Cemil Özcelik; Andreas Mügge; Alexander Wutzler
Journal:  J Interv Card Electrophysiol       Date:  2018-02-19       Impact factor: 1.900

3.  Initial Experience Using the Radiofrequency Needle Visualization on the Electroanatomical Mapping System for Transseptal Puncture.

Authors:  Silvia Guarguagli; Ilaria Cazzoli; Aleksander Kempny; Michael A Gatzoulis; Sabine Ernst
Journal:  Cardiol Res Pract       Date:  2020-06-20       Impact factor: 1.866

4.  Development of radiation exposure in patients undergoing pulmonary vein isolation in Germany between 2007 and 2014: great potential to minimize radiation dosage.

Authors:  Thomas Kleemann; Johannes Brachmann; Thorsten Lewalter; Dietrich Andresen; Stephan Willems; Stefan G Spitzer; Ellen Hoffmann; Lars Eckardt; Matthias Hochadel; Jochen Senges; Karl-Heinz Kuck; Karlheinz Seidl; Ralf Zahn
Journal:  Clin Res Cardiol       Date:  2016-05-03       Impact factor: 5.460

5.  Feasibility of zero or near zero fluoroscopy during catheter ablation procedures.

Authors:  Laurent M Haegeli; Linda Stutz; Mohammed Mohsen; Thomas Wolber; Corinna Brunckhorst; Chol-Jun On; Firat Duru
Journal:  Cardiol J       Date:  2018-04-03       Impact factor: 2.737

6.  Evaluation of a near-zero fluoroscopic approach for catheter ablation in patients with congenital heart disease.

Authors:  Óscar Cano; Assumpció Saurí; Diego Plaza; Joaquín Osca; María-José Sancho-Tello; Joaquín Rueda; Ana Osa; Luis Martínez-Dolz
Journal:  J Interv Card Electrophysiol       Date:  2018-10-30       Impact factor: 1.900

7.  Catheter radiofrequency ablation for arrhythmias under the guidance of the Carto 3 three-dimensional mapping system in an operating room without digital subtraction angiography.

Authors:  Xingfu Huang; Yanjia Chen; Zheng Huang; Liwei He; Shenrong Liu; Xiaojiang Deng; Yongsheng Wang; Rucheng Li; Dingli Xu; Jian Peng
Journal:  Medicine (Baltimore)       Date:  2018-06       Impact factor: 1.889

8.  Atrial Fibrillation Ablation Without Fluoroscopy: Because We Can.

Authors:  Rahul N Doshi
Journal:  J Innov Card Rhythm Manag       Date:  2018-11-15

9.  Continuous monitoring after atrial fibrillation ablation: the LINQ AF study.

Authors:  Simon Wechselberger; Mads Kronborg; Yan Huo; Judith Piorkowski; Sebastian Neudeck; Ellen Päßler; Ali El-Armouche; Utz Richter; Julia Mayer; Stefan Ulbrich; Liying Pu; Bettina Kirstein; Thomas Gaspar; Christopher Piorkowski
Journal:  Europace       Date:  2018-11-01       Impact factor: 5.214

10.  Comparison of radiation exposure between endoscopic ultrasound-guided drainage and transpapillary drainage by endoscopic retrograde cholangiopancreatography for pancreatobiliary diseases.

Authors:  Mamoru Takenaka; Makoto Hosono; Madan M Rehani; Yasutaka Chiba; Rei Ishikawa; Ayana Okamoto; Tomohiro Yamazaki; Atsushi Nakai; Shunsuke Omoto; Kosuke Minaga; Ken Kamata; Kentaro Yamao; Shiro Hayashi; Tsutomu Nishida; Masatoshi Kudo
Journal:  Dig Endosc       Date:  2021-08-19       Impact factor: 6.337

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.